Compound heterozygous mutation with a novel splice donor region DNA sequence variant in the succinate dehydrogenase subunit B gene in malignant paraganglioma

Pediatric Blood and Cancer

Volumn 54, Issue 3, 2010, Pages 473-475

  Majumdar, Suvankar ^a   Friedrich, Christopher A ^a   Koch, Christian A ^a,b   Megason, Gail C ^a   Fratkin, Jonathan D ^a   Moll, George W ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Congenital adrenal hyperplasia; Malignant; Paraganglioma; Pheochromocytoma; SDHB mutation

Indexed keywords

(3 IODOBENZYL)GUANIDINE; ARSENIC TRIOXIDE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; PROPRANOLOL; SUCCINATE DEHYDROGENASE; VINCRISTINE;

ADOLESCENT; ARTICLE; BRAIN SCINTISCANNING; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER SURGERY; CASE REPORT; CONGENITAL ADRENAL HYPERPLASIA; DNA SEQUENCE; FAMILY HISTORY; FOLLOW UP; GENE MUTATION; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPOPHYSIS ADENOMA; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAGANGLIOMA; PRIORITY JOURNAL; SINGLE DRUG DOSE; TUMOR BIOPSY;

ADOLESCENT; BRAIN NEOPLASMS; DNA, NEOPLASM; GENETIC VARIATION; GERM-LINE MUTATION; HUMANS; MALE; MUTATION, MISSENSE; PARAGANGLIOMA; PEDIGREE; RNA SPLICE SITES; SUCCINATE DEHYDROGENASE;

EID: 76749132493     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22338     Document Type: Article

References (16)

1. DeLellis RA, Lloyd RV, Heitz PU, et al. Pathology and molecular genetics of endocrine tumours. WHO classification of tumours of endocrine organs. Lyon: IARC Press; 2004.
2. Bryant J, Farmer J, Kessler LJ, et al. Pheochromocytoma: The expanding genetic differential diagnosis. J Natl Cancer Inst 2003; 95:1196-1204.
3. Neumann HP, Eng C. The approach to the patient with paraganglioma. J Clin Endocrinol Metab 2009;94:2677-2683.
4. Neumann HP, Bausch B, McWhinney SR, et al. Freiburg-Warsaw-Columbus Pheochromocytoma Study Group. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002;346: 1459-1466.
5. Brouwers FM, Eisenhofer G, Tao JJ, et al. High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: Implications for genetic testing. J Clin Endocrinol Metab 2006;91:4505-4509.
6. Pham TH, Moir C, Thompson GB, et al. Pheochromocytoma and paraganglioma in children: A review of medical and surgical management at a tertiary care center. Pediatrics 2006;118:1109-1114.
7. 131IMIBG and arsenic trioxide in patients with resistant neuroblastoma or malignant chromaffin cell tumors. Clin Trials.gov.NCT00107289.
8. Eisenhofer G, Siegert G, Kotzerke J, et al. Current progress and future challenges in the biochemical diagnosis and treatment of pheochromocytomas and paragangliomas. Horm Metab Res 2008;40:329-337. Review.
9. Pacak K, Eisenhofer G, Ahlman H, et al. International Symposium on Pheochromocytoma. Pheochromocytoma: Recommendations for clinical practice from the First International Symposium. Nat Clin Pract Endocrinol Metab 2007;3:92-102.
10. Jimenez C, Cote G, Arnold A, et al. Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes ? J Clin Endocrinol Metab 2006;91:2851-2858.
11. Amar L, Bertherat J, Baudin E, et al. Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 2005;23: 8812-8818.
12. Benn DE, Gimenez-Roqueplo AP, Reilly JR, et al. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. J Clin Endocrinol Metab 2006;91:827-836.
13. Huang SC, Koch CA, Vortmeyer AO, et al. Duplication of the mutant RET allele in trisomy 10 or loss of the wild-type allele in multiple endocrine neoplasia type 2-associated pheochromocytomas. Cancer Res 2000;60:6223-6226.
14. Baysal BE. Clinical and molecular progress in hereditary paraganglioma. J Med Genet 2008;45:689-694.
15. Merke DP, Chrousos GP, Eisenhofer G, et al. Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency. N Engl J Med 2000;343:1362-1368.
16. Ahmad S, Aaltonen LA, Georgitsi M, et al. Do single nucleotide polymorphisms in the AIP gene and MEN 1 gene predispose individuals to the development of familial isolated pituitary tumors? Exp Clin Endocrinol Diabetes 2007;115:S35-S36.